Innovating for Tomorrow, Our Commitment to Research & Development
our commitment to research and development (R&D) is the cornerstone of our mission to advance healthcare and improve lives.
Formulation Research and DevelopmentÂ
Leading the Way in Medical Innovation
As a WHO GMP certified pharmaceutical formulation unit, HML has a notable role in expanding access to essential medicines in various regions of the world by developing cost-effective, high-quality generics.
HML has a well-equipped development laboratory with major equipment like granulator, FBD, blender, coating machine and is actively involved in formulation development and process optimization for producing generic equivalents of innovator pharmaceutical products. Each new product undergoes the entire development cycle, from initial research, excipient compatibility studies and ICH stability, followed by BE studies for necessary regulatory approvals.
Approach
We believe that the key to transforming healthcare lies in constant innovation.
HML views formulation research and development as a key factor in producing generic products for the developing world, where access to affordable medication can have significant impact on public health.
Over the years, we have successfully launched numerous generic OSD pharmaceuticals. Our extensive pipeline ensures products that are not only effective and safe but also promptly available to those in need.
Pioneering the Next Generation of Medical Breakthroughs
Curious about our cutting-edge research and innovative developments? Learn how we’re transforming scientific discoveries into life-changing treatments.
Certifications
Certifications from Leading Global Health Authorities
ISO Certificate 001
